Published in Blood Weekly, July 29th, 2004
"Sierra will provide us with a highly skilled research organization that is already intimately familiar with EX-CYTE, the world leading cell culture media growth supplement," said David A. Dodd, president and CEO of Serologicals. Ex-CYTE is trademark of Serologicals Corporation.
Analysts estimate that the worldwide cell culture market in 2003 was approximately $850 million. Approximately 15% of this amount was attributable to services provided to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.